The Health Sciences Authority (HSA) has made available updated lists detailing new therapeutic product approvals and new indications for registered therapeutic products. These lists, published on March 11, 2026, provide current information for healthcare professionals and industry members regarding the regulatory status of various therapeutic products.

Regulated entities, particularly drug manufacturers and pharmaceutical companies, should review these updated lists to ensure their product information and compliance strategies align with the latest approvals and indications. While this is an informational update, staying abreast of these changes is crucial for ongoing regulatory compliance and market access.